This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Nanotechnol. 2023, 14, 240–261, doi:10.3762/bjnano.14.23
Figure 1: Examples of combinatorial therapy for (left) EGFR-dependent and (right) EGFR-independent TKI resist...
Figure 2: (A) Gefitinib-loaded gelatin-A NPs functionalized with a cetuximab-siRNA conjugate (Ab-SiRNA-GelGEF...
Figure 3: Nanotools for reversal of EGFR TKI resistance by RNAi. Favorable cell internalization was mediated ...
Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31
Figure 1: Hypothetical mechanisms of extravasation of NDDSs into the BM stroma. The nanoscale carrier could i...
Figure 2: Schematic representation of a polyrotaxane nanoconstruct bearing surface-oriented PTK7 aptamers for...
Figure 3: Wool-like hollow polycaprolactone (PCL) NDDS for the sequential co-delivery of imatinib mesylate (I...
Figure 4: EGFR targeting strategies using “non-conventional” ligands. (a) Heparin nanoparticles with surface-...
Figure 5: A multifunctional hyaluronan nanogel targeting EGFR and CD44. The binding of hyaluronan residues an...
Figure 6: HA-functionalized NDDS with multimodal targeting capabilities. (a) HA–paclitaxel (PTX) complex and ...